As Campbell Soup Co (CPB) Valuation Declined, Hamilton Point Investment Advisors Has Lifted Holding; Stralem & Co Has Lowered Abbott Labs Com (ABT) Position by $2.41 Million

June 12, 2018 - By Ellis Scott

Campbell Soup Company (NYSE:CPB) Logo

Stralem & Co Inc decreased its stake in Abbott Labs Com (ABT) by 14.95% based on its latest 2018Q1 regulatory filing with the SEC. Stralem & Co Inc sold 40,910 shares as the company’s stock rose 3.04% while stock markets declined. The institutional investor held 232,785 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $13.95 million, down from 273,695 at the end of the previous reported quarter. Stralem & Co Inc who had been investing in Abbott Labs Com for a number of months, seems to be less bullish one the $110.68 billion market cap company. The stock decreased 0.22% or $0.14 during the last trading session, reaching $63.13. About 5.34 million shares traded. Abbott Laboratories (NYSE:ABT) has risen 41.91% since June 12, 2017 and is uptrending. It has outperformed by 29.34% the S&P500. Some Historical ABT News: 17/04/2018 – FDA: Certain Implantable Cardiac Devices by Abbott (formerly St. Jude Medical): FDA Safety Communication – Battery Performance; 18/05/2018 – ABBOTT: TO STUDY LAWS FOR SAFER SCHOOLS, PROTECTING 2ND AMEND; 18/04/2018 – ABBOTT LABORATORIES – FORECASTS NET SPECIFIED ITEMS FOR FULL YEAR 2018 OF APPROXIMATELY $1.57 PER SHARE; 18/05/2018 – ABBOTT: SUSPECT MAY HAVE INTENDED TO COMMIT SUICIDE; 28/03/2018 – BIGFOOT BIOMEDICAL SAYS HAS COMPLETED $55 MLN SERIES B EQUITY FINANCING WITH NEW INVESTMENTS FROM ABBOTT, OTHER NEW & EXISTING INVESTORS; 18/04/2018 – ABBOTT LABORATORIES ABT.N FY2018 SHR VIEW $2.86 — THOMSON REUTERS l/B/E/S; 18/05/2018 – ABBOTT: A SHOTGUN AND A .38 REVOLVER WERE USED IN ATTACK; 18/04/2018 – ABBOTT LABORATORIES – QTRLY TOTAL DIAGNOSTICS SALES $ 1,837 MLN VS $1,158 MLN REPORTED LAST YEAR; 28/03/2018 – ASAHI Receives CTO lndication for Corsair and Coronary Guide Wires; 29/03/2018 – Boston Scientific and Abbott have also recently unveiled new systems

Hamilton Point Investment Advisors Llc increased its stake in Campbell Soup Co (CPB) by 77.49% based on its latest 2018Q1 regulatory filing with the SEC. Hamilton Point Investment Advisors Llc bought 29,745 shares as the company’s stock declined 22.02% with the market. The institutional investor held 68,130 shares of the packaged foods company at the end of 2018Q1, valued at $2.95M, up from 38,385 at the end of the previous reported quarter. Hamilton Point Investment Advisors Llc who had been investing in Campbell Soup Co for a number of months, seems to be bullish on the $10.47 billion market cap company. The stock increased 2.29% or $0.78 during the last trading session, reaching $34.83. About 5.91M shares traded or 49.71% up from the average. Campbell Soup Company (NYSE:CPB) has declined 41.19% since June 12, 2017 and is downtrending. It has underperformed by 53.76% the S&P500. Some Historical CPB News: 09/05/2018 – Kraft Heinz seeks buzz for big brands as rivals’ valuations come down; 18/05/2018 – Campbell Soup: Denise M. Morrison, Pres and CEO, Retires Effective Today; 18/05/2018 – Campbell Soup CEO quits abruptly; firm to review portfolio, cuts forecast; 30/04/2018 – Fidelity Value Discovery Adds Hershey, Exits Campbell Soup; 05/04/2018 – CAMPBELL REPORTS STRATEGIC REORGANIZATION; 23/03/2018 – Snyder’s-Lance, Inc. Receives Shareholder Approval for Proposed Acquisition by Campbell Soup Co; 21/05/2018 – CAMPBELL SOUP’S BAA2/PRIME-2 MAY BE CUT BY MOODY’S; 25/04/2018 – Snyder’s of Hanover Introduces Five New Products for 2018; 21/03/2018 – Campbell Board Elects Maria Teresa Hilado as Director; 23/03/2018 – SNYDER’S-LANCE, GETS HOLDER OK FOR ACQUISITION BY CAMPBELL SOUP

Since December 20, 2017, it had 2 insider buys, and 1 insider sale for $46,193 activity. 2,000 shares valued at $66,431 were bought by Hilado Maria Teresa on Wednesday, June 6. The insider Mignini Luca bought $200,351.

Among 17 analysts covering Campbell Soup (NYSE:CPB), 2 have Buy rating, 8 Sell and 7 Hold. Therefore 12% are positive. Campbell Soup had 64 analyst reports since July 23, 2015 according to SRatingsIntel. The company was maintained on Monday, January 23 by Stifel Nicolaus. The stock of Campbell Soup Company (NYSE:CPB) earned “Sector Perform” rating by RBC Capital Markets on Thursday, February 18. As per Friday, January 15, the company rating was downgraded by Barclays Capital. The rating was downgraded by Argus Research on Monday, September 19 to “Hold”. The stock of Campbell Soup Company (NYSE:CPB) earned “Sector Perform” rating by RBC Capital Markets on Thursday, July 23. Deutsche Bank maintained Campbell Soup Company (NYSE:CPB) on Friday, August 26 with “Hold” rating. The firm earned “Underperform” rating on Monday, April 16 by Credit Suisse. The firm earned “Underperform” rating on Tuesday, March 21 by Bernstein. Citigroup upgraded the stock to “Buy” rating in Tuesday, January 16 report. On Thursday, November 23 the stock rating was maintained by UBS with “Sell”.

Hamilton Point Investment Advisors Llc, which manages about $219.06 million and $196.99 million US Long portfolio, decreased its stake in Schwab Charles Corp New (NYSE:SCHW) by 48,380 shares to 88,210 shares, valued at $4.61M in 2018Q1, according to the filing.

More notable recent Campbell Soup Company (NYSE:CPB) news were published by: Seekingalpha.com which released: “Campbell Soup: Mmm Mmm Capitulation” on May 24, 2018, also Seekingalpha.com with their article: “Chow Down On Campbell’s Souped Up 4% Dividend” published on May 30, 2018, Seekingalpha.com published: “No Soup For You, Campbell Investors!” on May 21, 2018. More interesting news about Campbell Soup Company (NYSE:CPB) were released by: 247Wallst.com and their article: “6 Most Important Things in Business Today” published on May 21, 2018 as well as Seekingalpha.com‘s news article titled: “Value In The Soup Giant” with publication date: May 16, 2018.

Investors sentiment increased to 1.25 in 2018 Q1. Its up 0.19, from 1.06 in 2017Q4. It improved, as 43 investors sold CPB shares while 137 reduced holdings. 64 funds opened positions while 161 raised stakes. 142.87 million shares or 2.90% less from 147.14 million shares in 2017Q4 were reported. Armistice owns 628,000 shares. Litman Gregory Asset Management Ltd Liability Com reported 0% stake. Horrell owns 500 shares. Fifth Third State Bank owns 11,465 shares. First Allied Advisory Services Incorporated holds 0.03% of its portfolio in Campbell Soup Company (NYSE:CPB) for 18,040 shares. Tarbox Family Office holds 6 shares or 0% of its portfolio. Alphaone Limited Co invested in 0.01% or 590 shares. Moreover, Boulegeris Invests has 0.66% invested in Campbell Soup Company (NYSE:CPB) for 27,746 shares. Credit Suisse Ag reported 0.02% in Campbell Soup Company (NYSE:CPB). Covington holds 1,000 shares. Clifford Swan Invest Counsel Limited Co invested in 0.02% or 9,253 shares. Whittier Tru Of Nevada Inc accumulated 2,498 shares. Chevy Chase Tru Inc has invested 0.03% in Campbell Soup Company (NYSE:CPB). Security Natl Trust Co has invested 0.01% of its portfolio in Campbell Soup Company (NYSE:CPB). Gamble Jones Investment Counsel has 0.05% invested in Campbell Soup Company (NYSE:CPB).

Since December 14, 2017, it had 1 insider buy, and 20 selling transactions for $22.32 million activity. 40,037 shares were bought by STARKS DANIEL J, worth $2.43M on Tuesday, February 27. $27,213 worth of Abbott Laboratories (NYSE:ABT) was sold by PEDERSON MICHAEL J on Friday, February 16. Salvadori Daniel Gesua Sive also sold $53,369 worth of Abbott Laboratories (NYSE:ABT) shares. Shares for $62,056 were sold by Bracken Sharon J. On Tuesday, January 30 the insider Ford Robert B sold $2.69M. The insider Watkin Jared sold 3,000 shares worth $183,579.

Investors sentiment decreased to 0.83 in 2018 Q1. Its down 0.08, from 0.91 in 2017Q4. It turned negative, as 44 investors sold ABT shares while 606 reduced holdings. 126 funds opened positions while 411 raised stakes. 1.22 billion shares or 0.54% more from 1.22 billion shares in 2017Q4 were reported. Waters Parkerson & Ltd Llc accumulated 523,452 shares. Pioneer Trust Fincl Bank N A Or reported 68,960 shares. Winslow Evans And Crocker has invested 0% in Abbott Laboratories (NYSE:ABT). Morgan Stanley accumulated 15.94M shares. Pure Financial Advsrs owns 11,435 shares for 0.17% of their portfolio. Auxier Asset Management has invested 1.25% of its portfolio in Abbott Laboratories (NYSE:ABT). Cubist Systematic Strategies Limited Liability Company owns 74,946 shares. Envestnet Asset, a Illinois-based fund reported 137,487 shares. Sector Gamma As reported 1.11M shares. Brighton Jones owns 0.07% invested in Abbott Laboratories (NYSE:ABT) for 8,205 shares. 85,628 are owned by Pineno Levin & Ford Asset Management Inc. The Georgia-based Chatham has invested 0.33% in Abbott Laboratories (NYSE:ABT). Weatherstone Management holds 0.17% in Abbott Laboratories (NYSE:ABT) or 3,783 shares. S&Co owns 280,380 shares. Oppenheimer & Company owns 127,819 shares or 0.2% of their US portfolio.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 107 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Thursday, August 27 by Wells Fargo. The rating was maintained by Cowen & Co on Friday, September 22 with “Buy”. The stock of Abbott Laboratories (NYSE:ABT) has “Buy” rating given on Thursday, July 23 by Stifel Nicolaus. Guggenheim maintained the stock with “Buy” rating in Thursday, January 25 report. As per Tuesday, January 2, the company rating was upgraded by JP Morgan. BTIG Research maintained the stock with “Buy” rating in Saturday, August 29 report. The firm has “Buy” rating by Jefferies given on Thursday, July 14. The firm earned “Equal-Weight” rating on Thursday, October 19 by Morgan Stanley. Barclays Capital maintained the shares of ABT in report on Thursday, September 28 with “Overweight” rating. BMO Capital Markets downgraded the stock to “Market Perform” rating in Tuesday, March 14 report.

Abbott Laboratories (NYSE:ABT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>